Table 1.
Microbiome and metabolome glossary.
| Term | Definition |
|---|---|
| Psychoneurological symptoms | Symptoms that often co-occur and have similar potential underlying causal pathways. Examples include pain, fatigue, sleep disturbance, anxiety, depressive symptoms, and cognitive dysfunction. |
| Microbiome | A community of microorganisms (bacteria, viruses, and fungi) that reside in different parts of the human body, such as the skin, gastrointestinal tract, oral cavity, and vagina. |
| Microbial composition | A description of the microorganisms that form the microbiome. Compositional components include microbial abundance and diversity metrics (alpha and beta diversity). |
| Microbial abundance | The quantity or proportion (relative abundance) of a specific microorganism that resides in the microbiome. |
| Alpha diversity | Measurement of microbial species diversity within a given sample or microbial site. |
| Beta diversity | Measurement of dissimilarity (or similarity) of species diversity between two or more samples or microbial sites. |
| Metabolome | The collection of small molecules (metabolites) and their interactions within a specific biological system or sample. |
| Metabolites | Small molecules that are substrates, intermediates, or products of metabolic reactions that regulate various physiological functions within a cell or organism. |
| Untargeted metabolomics | An analytical approach that aims to comprehensively detect and quantify metabolites within a sample due to limited prior knowledge; often used as an exploratory tool. |
| Targeted metabolomics | An analytical approach that aims to quantify specific types of metabolites within a sample based on known relevant metabolic pathways or physiological processes. |
| Metabolomic pathway | A sequence of chemical reactions that produce new molecules (synthesis) or breakdown complex molecules (degradation). |